CSYS yields 200000000.00% · JNJ yields 2.14%● Live data
📍 CSYS pulled ahead of the other in Year 1
Combined, CSYS + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CSYS + JNJ for your $10,000?
ClearStory Systems, Inc. develops digital asset management (DAM) and enterprise content management software solutions. The company offers Radiant Enterprise Media Server (RADIANT EMS), a J2EE platform for document and media solutions; ActiveMedia, an enterprise DAM application that is built on Radiant EMS platform, which offers a secure central repository where rich media files, such as images, documents, video, animation, and voice formats of media and brand assets are organized and stored; Radiant Business Document Server, a system for document capture, archiving, and online presentment; and Radiant Mailmanager, an email archiving solution that provides lifecycle, compliance, and storage management for the corporate email knowledge. It also provides standards based technology solution, a platform for integrating media and business documents into various business environments, such as marketing and finance departments, call centers, channel partner portals, compliance initiatives, and marketing extranets. The company serves media and entertainment, pharmaceutical, consumer packaged goods, financial services, and healthcare industries. ClearStory Systems, Inc. was formerly known as INSCI Corp. and changed its name to ClearStory Systems, Inc. in December 2001. The company was founded in 1989. The company is based in Westborough, Massachusetts. ClearStory Systems, Inc. operates as a subsidiary of Piksel, Inc.
Full CSYS Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.